# Enhancing Rehabilitation in Aging Study (ERAS)

> **NCT07704385** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Florida** · enrollment: 38 (estimated)

## Conditions studied

- Adults

## Interventions

- **DRUG:** Istradefylline 20 mg
- **DRUG:** Placebo
- **OTHER:** Acute Intermittent Hypoxia (AIH)

## Key facts

- **NCT ID:** NCT07704385
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2031-05-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704385, "Enhancing Rehabilitation in Aging Study (ERAS)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07704385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*